NCT02999295 2019-08-21A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ CancerNational Cancer Center, JapanPhase 1/2 Completed46 enrolled
NCT02781155 2016-05-24Limiting Chemotherapy Side Effects by Using MoxaEast and North Hertfordshire NHS TrustPhase 1/2 Unknown25 enrolled